Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information



Palo Alto, USA
2100 Geng Road, Suite 200
Palo Alto, CA, 94303


Managing Partner
Limited Partner Founder
Fund Accountant


Asset Management Company

Asset Management Company is a Silicon Valley venture capital firm. Since 1965, the company has been on the cutting edge, identifying the best ideas and the best people in the information technology and life sciences sectors. Specializing in seed and early stage funding, Asset Management has built a history of being ahead for nearly four decades.

Recent Milestones


Company Date Round Size Participants
Esperion Therapeutics 4/2013Venture Round$33M7
CardioDx 7/2012Private Equity$30.5M14
Keepsafe 2/2012Seed$700k4
CardioDx 5/2011Private Equity$60M14
Chimerix 2/2011Series F$45M8
CardioDx 5/2010Series D$34.5M9
OfferIQ 3/2010Venture Round2
HighTower Advisors 1/2010Private Equity$100M2
Coapt Systems 12/2009Debt$3.72M8
Servo Software 12/2009Series B$3.01M1
Invaluable 12/2009Venture Round$13M2
Brilliant Telecommunications 10/2009Venture Round$7.6M6
Chimerix 8/2009Series E$16.1M4
iScience Interventional 5/2009Series F$20.5M8
BiPar Sciences 1/2009Series C$20M6
InteKrin 8/2008Series C$18.5M7
Loomia 4/2008Series A$5M3
Stratavia 7/2007Series B$6.25M3
ViaCyte 7/2007Series C$25M4
Sonoma Orthopedics 5/2007Series B$10M4
Coapt Systems 3/2007Series E$22.6M7
BiPar Sciences 2/2007Series B$35M6
Chimerix 2/2007Series D$23.1M4
Brilliant Telecommunications 2/2007Series A$7.1M4
Athena Design Systems 1/2007Series B$4M6
db4objects 1/2007Series A5
Novare Surgical 10/2006Series D$16M6
ViaCyte 5/2006Venture Round$20M8
Corrigo 6/2005Series D$10M4
BiPar Sciences 12/2004Series A$13M5
Chimerix 11/2004Series C$11M3
CAPNIA 5/2004Series B$12M3



  1. Esperion Therapeutics Completes $33 Million Preferred Financing to Advance Its Novel Oral LDL-C Lowering Therapy to Later Stage Clinical Trials ( [edit]
  2. VC Funding: Q3 2012 source [edit]
  3. Company announcement ( [edit]
  4. CardioDx Closes $60m Financing Round ( [edit]
  5. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 ( [edit]
  6. CardioDx, Inc.: Series D $34.5M ( [edit]
  7. Metamorphic Ventures Backs OfferIQ ( [edit]
  8. HighTower Closes $100M Equity Financing ( [edit]
  9. Coapt Systems takes $3.7M for facial rejuvenation ( [edit]
  10. Servo, SEC D ( [edit]
  11. Artfact Raises $13M and Merges with Auctionzip ( [edit]
  12. Brilliant Secures $7.6 Million in Funding from ONSET Ventures and NovAtel for Next-Generation Timing and Synchronization ( [edit]
  13. VC insiders inject $16M into Chimerix ( [edit]
  14. iScience Interventional, Inc.: Series F $20.5M ( [edit]
  15. BiPar Sciences Raises $20 Million to Advance Clinical Programs ( [edit]
  16. InteKrin raises $18.5M for continued work on diabetes drug ( [edit]
  17. Loomia raises $5M to make recommendations ( [edit]
  19. Novocell Raises $25 Million ( [edit]
  20. Sonoma Orthopedics raises at least $10M for spinal devices ( [edit]
  21. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more ( [edit]
  22. BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates ( [edit]
  23. Chimerix Raises $23.1 Million to Advance Antiviral Drug Pipeline ( [edit]
  24. Brilliant, a network server technology co., raises $7.1M ( [edit]
  25. Athena Design Completes Series B Funding, Two New Investors Join EDA Start-up ( [edit]
  26. Citation Needed [add]
  27. Novare raises $16 million for less invasive surgery instruments ( [edit]
  28. EDGAR [edit]
  29. EDGAR [edit]
  30. BiPar Sciences Raises $13 Million in Series A Financing ( [edit]
  31. Chimerix Raises $11 Million ( [edit]
  32. Capnia Secures $12 Million Series B ( [edit]
Edit This Page
Last Edited 3/11/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy